This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-09-0116v1 69/18/7412    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Jin, B. Articles by Robertson, K. D. PubMed PubMed Citation Articles by Jin, B. Articles by Robertson, K. D.

DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer

¹ Department of Biochemistry and Molecular Biology and Cancer Research Center, Medical College of Georgia, Augusta, Georgia and Departments of ² Biochemistry and Molecular Biology and ³ Pathology and ⁴ Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, Florida

Requests for reprints: Keith D. Robertson, Department of Biochemistry and Molecular Biology and Cancer Research Center, Medical College of Georgia, Augusta, GA 30912. Phone: 706-721-0099; Fax: 706-721-1670; E-mail: krobertson{at}mcg.edu.

Key Words: colon cancer • DNA methylation • polycomb

DNA methylation patterns are established and maintained by three DNA methyltransferases (DNMT): DNMT1, DNMT3A, and DNMT3B. Although essential for development, methylation patterns are frequently disrupted in cancer and contribute directly to carcinogenesis. Recent studies linking polycomb group repression complexes (PRC1 and PRC2) to the DNMTs have begun to shed light on how methylation is targeted. We identified previously a panel of genes regulated by DNMT3B. Here, we compare these with known polycomb group targets to show that 47% of DNMT3B regulated genes are also bound by PRC1 or PRC2. We chose 44 genes coregulated by DNMT3B and PRC1/PRC2 to test whether these criteria would accurately identify novel targets of epigenetic silencing in colon cancer. Using reverse transcription-PCR, bisulfite genomic sequencing, and pyrosequencing, we show that the majority of these genes are frequently silenced in colorectal cancer cell lines and primary tumors. Some of these, including HAND1, HMX2, and SIX3, repressed cell growth. Finally, we analyzed the histone code, DNMT1, DNMT3B, and PRC2 binding by chromatin immunoprecipitation at epigenetically silenced genes to reveal a novel link between DNMT3B and the mark mediated by PRC1. Taken together, these studies suggest that patterns of epigenetic modifiers and the histone code influence the propensity of a gene to become hypermethylated in cancer and that DNMT3B plays an important role in regulating PRC1 function. [Cancer Res 2009;69(18):7412–21]